https://doi.org/10.4081/aiua.2022.1.62

Propionibacterium acnes in urine and semen samples from men with urinary infection

Vol. 94 No. 1 (2022)
Submitted: October 18, 2021
Accepted: December 3, 2021
Published: March 29, 2022
Propionibacterium acnes, Prostate hyperplasia, Prostate cancer, Urinary tract infections
Abstract Views: 1000
PDF: 686
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Lucrezia Manente
l_manente@yahoo.it
Biodata s.r.l Clinical, Molecular and Genetics Laboratory, Salerno, Italy.
Umberto Gargiulo
Biodata s.r.l Clinical, Molecular and Genetics Laboratory, Salerno, Italy.
Paolo Gargiulo
Biodata s.r.l Clinical, Molecular and Genetics Laboratory, Salerno, Italy.
Giuseppe Dovinola
Specialist Urology and Andrology Clinic, Salerno, Italy.

Objective: Propionibacterium acnes has been implicated in the pathogenesis of prostate disease as acute and chronic prostatic inflammation, benign prostatic hyperplasia and prostate cancer although it should still be clarified if Propionibacterium acnes (P. acnes) is a commensal or accidental prostate pathogen. Aiming to evaluate the pathogenic potential for genitourinary tract of Propionibacterium acnes, we investigated the frequency of P. acnes genome in urine or semen samples from men with recurrent symptoms of urinary infection and negative testing for the most common urinary tract pathogens and sexually transmitted infections (STI) agents as Chlamydia trachomatis, Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum.
Materials and methods: The DNA extracted from urine and semen samples was analyzed for evaluating the P. acnes genome presence by real-time polymerase chain reaction (PCR). Infections were treated with vancomycin and cephalosporins antibiotics and then the search for the P.acnes genome by realtime PCR was repeated.
Results: The P. acnes qualitative real-time PCR revealed the genome in 73 out of 159 samples examined (108 urine and 51 semen). After antibiotic therapy, P. acnes was never detected.
Conclusions: These results suggested that P. acnes genome determination should be performed in cases of chronic inflammation in the urinary tract to identify an unknown potential pathogen of genitourinary tract.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
Leheste JR, Ruvolo KE, Chrostowski JE, et al. P. acnes-driven disease pathology: current knowledge and future directions. Front Cell Infect Microbiol. 2017; 7:81. DOI: https://doi.org/10.3389/fcimb.2017.00081
Kakegawa T, Bae Y, Ito T, et al. Frequency of Propionibacterium acnes infection in prostate glands with negative biopsy results is an independent risk factor for prostate cancer in patients with increased serum PSA titers. PLoS One. 2017; 12:e0169984 DOI: https://doi.org/10.1371/journal.pone.0169984
Shannon BA, Cohen RJ, Garrett KL. The antibody response to Propionibacterium acnes is an independent predictor of serum prostate-specific antigen levels in biopsy-negative men. BJU Int. 2008; 101:429-35.
Griebling TL. Urologic Diseases in America project: trends in resource use for urinary tract infections in men. J Urol. 2005;173:1288-94. DOI: https://doi.org/10.1097/01.ju.0000155595.98120.8e
Marques LP, Flores JT, de Barros O, et al. Epidemiological and clinical aspects of urinary tract infection in community-dwelling elderly women. Braz J Infect Dis. 2012; 16:436-41. DOI: https://doi.org/10.1016/j.bjid.2012.06.025
Gandaglia G, Zaffuto E, Fossati N, et al. The role of prostatic inflammation in the development and progression of benign and malignant diseases. Curr Opin Urol. 2017; 27:99-106. DOI: https://doi.org/10.1097/MOU.0000000000000369
De Marzo AM, Platz EA, Sutcliffe S, et al. Inflammation in prostate carcinogenesis. Nat Rev Cancer. 2007; 7:256-269. DOI: https://doi.org/10.1038/nrc2090
Alexeyev O, Bergh J, Marklund I, et al. Association between the presence of bacterial 16S RNA in prostate specimens taken during transurethral resection of prostate and subsequent risk of prostate cancer (Sweden). Cancer Causes Control. 2006; 17:1127-1133. DOI: https://doi.org/10.1007/s10552-006-0054-2
Fassi Fehri L, Mak TN, Laube B, et al. Prevalence of Propionibacterium acnes in diseased prostates and its inflammatory and transforming activity on prostate epithelial cells. Int J Med Microbiol. 2011; 301:69-78. DOI: https://doi.org/10.1016/j.ijmm.2010.08.014
Perry AL, Lambert PA. Propionibacterium acnes. Lett Appl Microbiol. 2006; 42:185-8. DOI: https://doi.org/10.1111/j.1472-765X.2006.01866.x
Cai T, Pisano F, Nesi G et al. Chlamydia trachomatis versus common uropathogens as a cause of chronic bacterial prostatitis: is there any differences? Results of a prospective parallel-cohort study. Investig Clin Urol. 2017; 58:460-467. DOI: https://doi.org/10.4111/icu.2017.58.6.460
Horner PJ, Martin DH. Mycoplasma genitalium infection in men. J Infect Dis. 2017; 216:S396-405. DOI: https://doi.org/10.1093/infdis/jix145
Davidsson, S, Mölling P, Rider JR, et al. Frequency and typing of Propionibacterium acnes in prostate tissue obtained from men with and without prostate cancer. Infect. Agent Cancer. 2016; 11:36. DOI: https://doi.org/10.1186/s13027-016-0074-9

How to Cite

Manente, L., Gargiulo, U., Gargiulo, P., & Dovinola, G. (2022). Propionibacterium acnes in urine and semen samples from men with urinary infection. Archivio Italiano Di Urologia E Andrologia, 94(1), 62–64. https://doi.org/10.4081/aiua.2022.1.62

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.